A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

NCT02032888 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Daclatasvir
DRUG: Sofosbuvir

Sponsor

Bristol-Myers Squibb